Home » Topics » Regulatory » Patents

Patents
RSS

Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent

Jan. 19, 2009

Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia

Jan. 19, 2009

Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin

Jan. 19, 2009

New non-nucleoside reverse transcriptase inhibitors prepared and tested at GSK

Jan. 16, 2009

Novel anticancer PI3Kalpha inhibitors developed at GSK

Jan. 16, 2009

New York University discloses new antimicrobial triazine compounds

Jan. 16, 2009

Schering-Plough scientists claim new KSP inhibitors with anticancer properties in recent patent

Jan. 16, 2009

Roche divulges new GPCR-targeting antibodies for diabetes and neurological disorders

Jan. 16, 2009

Novel modulators of sodium and/or calcium channels under development at Newron

Jan. 15, 2009

Merck & Co. discloses novel orexin receptor antagonists for insomnia

Jan. 15, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...